Industry Welcomes Mandatory eCTD In Australia, But With Caveats
Executive SummaryThe Australian regulator, TGA, is currently assessing responses to last year’s consultation on the mandatory use of the eCTD for prescription drug submissions. Industry is mostly happy with the proposal, but has some concerns over the implementation process and certain technical issues.
You may also be interested in...
The Health Sciences Authority will seek industry’s feedback on the plans it has for introducing in Singapore the electronic format of the common technical document that drug companies use to make their regulatory submission.
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.